Table 1.
Study sponsor (study name) | Principal investigator | Country of study | Study period | Control source | Cases | Controls | Participation rate (%) |
|
---|---|---|---|---|---|---|---|---|
Cases | Controls | |||||||
North American and European studies | ||||||||
Central and Eastern Europe (CEE) | P. Boffetta | Central and Eastern Europe | 1998–2002 | Hospital based | 2,861 | 2,936 | 84 | 85 |
University of California–Los Angeles (California) | Z.F. Zhang | United States | 1999–2004 | Population based | 611 | 1,040 | 39 | 72 |
New England Lung Cancer Study (New England) | E. Duell | United States | 2005–2008 | Population based | 277 | 251 | 61 | 46 |
Samuel Lunenfeld Research Institute (Toronto) | J. McLaughlin | Canada | 1997–2002 | Population and hospital based | 445 | 962 | 62 | 71 |
Asian studies | ||||||||
National University of Singapore (Singapore) | A. Seow | Singapore | 1996–1998 | Hospital based | 303 | 763 | 95 | 97 |
National Cancer Institute (Xuanwei1) | Q. Lan | China | 1985–1990 | Population based | 498 | 498 | 100 | 97 |
National Cancer Institute (Xuanwei2) | Q. Lan | China | 1995–1996 | Population based | 122 | 122 | 98 | 100 |
As previously reported by Hashibe et al. (2006; California), Heck et al. (2009; New England), Hung et al. (2008; Toronto), Lan et al. (2000; Xuanwei2), Lan et al. (2008; Xuanwei1), Scélo et al. (2004; CEE), and Seow et al. (2000; Singapore).